Standard Operating Procedure for Management Review of Regulatory Performance Metrics

Department	Regulatory Affairs
SOP No.	RA/2026/796
Supersedes	NA
Page No.	1 of X
Issue Date	18/04/2026
Effective Date	18/04/2026
Review Date	18/04/2028

Purpose

This Standard Operating Procedure (SOP) establishes a controlled and systematic approach for conducting management reviews of regulatory performance metrics. The objective is to ensure ongoing compliance with applicable regulatory requirements, identify areas of improvement in regulatory operations, and support continuous enhancement of regulatory governance and cross-functional coordination within the organization.

Scope

This SOP applies to all regulatory affairs activities within the organization including, but not limited to, regulatory submissions, documentation control, compliance monitoring, and performance tracking across all product lines, dosage forms, and regulatory jurisdictions. It encompasses data collection, analysis, review meetings, and subsequent action implementation related to regulatory performance metrics. This SOP excludes operational procedures related to manufacturing, laboratory testing, and other non-regulatory activities.

Responsibilities

The following functional roles are involved in executing and supporting this SOP:

• Regulatory Affairs Analysts – Collect and compile regulatory performance data.
• Quality Assurance – Review compliance status and audit outcomes.
• Regulatory Affairs Manager – Coordinate review meetings and oversee documentation.
• Cross-Functional Team Members – Provide inputs regarding regulatory challenges and improvement opportunities.
• Management Representatives – Review, approve actions, and allocate resources.
• Documentation Control Personnel – Ensure secure and accurate record retention.

Accountability

The Regulatory Affairs Head is accountable for the implementation, continual compliance, and effectiveness of this SOP. This role ensures timely scheduling of management reviews, oversees resolution of identified issues, escalates critical risks, and drives improvements based on review outcomes.

Procedure

1. Preparation: Regulatory Affairs Analysts shall gather and validate all relevant regulatory performance data including submission timelines, approval rates, audit findings, training completion, and compliance incident reports at least two weeks prior to the scheduled management review meeting.

2. Prerequisites and Checks: Confirm availability of updated metrics reports, ensure completeness of documentation, verify compliance with data integrity standards, and confirm all cross-functional representatives required for the meeting are informed well in advance.

3. Conducting the Management Review Meeting: The Regulatory Affairs Manager shall chair the meeting following a structured agenda covering:

• Review of key regulatory performance indicators.
• Summary of compliance issues, deviations, and audit outcomes.
• Assessment of training effectiveness related to regulatory compliance.
• Analysis of workflow efficiency and identified bottlenecks.
• Discussion of regulatory submission status and timelines.
• Identification of risks and opportunities for process improvement.
• Decision-making on corrective and preventive actions.

4. Documentation: A designated recorder shall document meeting minutes, including attendance, discussions, decisions, action items, and assigned responsibilities. The final minutes shall be reviewed and approved by the Regulatory Affairs Manager.

5. Post-Meeting Actions: Assigned personnel shall implement agreed corrective and preventive measures within defined timelines. Progress shall be monitored and reported in subsequent management reviews.

6. Record Retention: All records related to the management review, including data reports, meeting minutes, action plans, and follow-up status reports, shall be retained per organizational document control procedures and applicable regulatory requirements.

7. Deviations and Escalations: Any deviations from this procedure or identified risks exceeding pre-established thresholds shall be escalated immediately to the Regulatory Affairs Head for prompt resolution.

This procedure must be periodically reviewed to ensure alignment with evolving regulatory requirements and organizational quality standards.

Abbreviations

GMP: Good Manufacturing Practice
SOP: Standard Operating Procedure
QA: Quality Assurance
RA: Regulatory Affairs
CAPA: Corrective and Preventive Action

Documents

1. Regulatory Performance Metrics Report (Annexure-1)
2. Management Review Meeting Minutes Template (Annexure-2)
3. Corrective and Preventive Action (CAPA) Log (Annexure-3)

References

International Council for Harmonisation (ICH) Q10 Pharmaceutical Quality System, FDA 21 CFR Part 11 (Electronic Records), EU GMP Guidelines, ISO 9001:2015 Quality Management Systems, Organization’s Quality Manual, and internal regulatory governance frameworks.

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Regulatory Performance Metrics Report

Purpose: To provide a structured and comprehensive summary of regulatory performance indicators to support the management review process.

Metric	Reporting Period	Target	Actual	Comments
Regulatory Submission Timeliness	01/01/2026 to 31/03/2026	≥ 95%	92%	Delays due to resource constraints in Q1
Approval Rate	01/01/2026 to 31/03/2026	≥ 98%	99%	Meets regulatory expectations
Compliance Training Completion	01/01/2026 to 31/03/2026	100%	97%	Two staff pending completion
Audit Findings Closed On Time	01/01/2026 to 31/03/2026	100%	95%	One overdue CAPA in progress
Regulatory Non-Compliance Events	01/01/2026 to 31/03/2026	0	0	No incidents reported

Annexure-2: Management Review Meeting Minutes Template

Purpose: To capture discussions, decisions, and action items from the regulatory performance management review meeting.

Date:	15/04/2026
Location:	Regulatory Affairs Conference Room
Attendees:	Regulatory Affairs Manager, QA Lead, RA Analysts, Cross-Functional Representatives
Agenda Items:	Review of Regulatory Performance Metrics Discussion of Compliance and Training Status Review of Audit Findings and CAPA Progress Identification of Risks and Opportunities Decision on Corrective Actions
Key Discussions:	Submission timeliness slightly below target due to resource reallocation. Training completion near 97%, follow-up planned. CAPA overdue item under active management. No new regulatory incidents.
Decisions Made:	Increase monitoring of submission timelines. Schedule additional training sessions for pending staff. Escalate CAPA delays to higher management if unresolved by next review.
Action Items:	Action Responsible Due Date Status Follow up on training completion Regulatory Affairs Analyst 30/04/2026 Open Monitor CAPA progress for overdue item QA Lead 15/05/2026 Open Report submission delays and mitigation plan Regulatory Affairs Manager 30/04/2026 Open
Next Meeting:	15/10/2026
Minutes Prepared By:
Minutes Reviewed & Approved By:

Annexure-3: Corrective and Preventive Action (CAPA) Log

Purpose: To document and track CAPA activities arising from management review findings and other regulatory compliance issues.

CAPA No.	Date Raised	Issue Description	Root Cause	Corrective Action	Preventive Action	Responsible	Target Completion Date	Status	Comments
CAPA-2026-001	20/03/2026	Delay in regulatory submission timelines	Insufficient resource allocation during peak period	Reassign additional personnel to submission tasks	Establish quarterly resource planning reviews	Regulatory Affairs Manager	30/04/2026	In Progress	Additional staff onboarded 10/04/2026
CAPA-2026-002	05/02/2026	Training completion below target	Scheduling conflicts and lack of follow-up	Implement mandatory compliance training calendar with reminders	Quarterly training status audits	Quality Assurance Lead	31/03/2026	Closed	Training compliance improved to 100%

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
18/04/2026	1.0	Initial issue	New SOP creation